Neuropeptide degrading enzyme(s) in plasma and brain: Effects of in vivo neuroleptic administration
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 14 (4) , 341-348
- https://doi.org/10.1016/s0031-6989(82)80104-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Inhibition of enkephalin-degrading enzymes from rat brain and of thermolysin by amino acid hydroxamatesLife Sciences, 1980
- Enkephalin inactivation by N-terminal tyrosine cleavage: Purification and partial characterization of a highly specific enzyme from human brainLife Sciences, 1980
- Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin converting enzymeLife Sciences, 1979
- ‘Enkephalinase’ is distinct from brain ‘angiostensin-converting enzyme’European Journal of Pharmacology, 1979
- Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatumBrain Research, 1979
- Monkey Brain ArylamidaseThe Journal of Biochemistry, 1978
- High-affinity enkephalin-degrading peptidase in brain is increased after morphineNature, 1978
- Localisation and characterisation of aminopeptidases in the CNS and the hydrolysis of enkephalinNature, 1978
- Enkephalin catabolism in vitro and in vivoNeuropharmacology, 1977
- Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenatesNature, 1976